During the past decade, California Retina Research Consultants conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "California Retina Research Consultants" are "Macular Edema" (1 trials), "Neovascular Age-Related Macular Degeneration" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "California Retina Research Consultants" in a lesser frequency.

Most popular intervention types in "California Retina Research Consultants" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (1 trials), "Drug: GB-102" (1 trials), "IVT aflibercept" (1 trials), "suprachoroidal CLS-TA" (1 trials) and "suprachoroidal sham" (1 trials). Other intervention names were less common.

The vast majority of trials in "California Retina Research Consultants" are 2 trials for "All" genders.

Currently, there are NaN active trials in "California Retina Research Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in California Retina Research Consultants, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in California Retina Research Consultants, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".